Showing results (61-70 of 1,646) with videos related to
Sort By:
Pageof 165
Lancet (London, England)|August 11, 1990
Vaccine-induced escape mutant of hepatitis B virusW F Carman, A R Zanetti, P Karayiannis, et al.Gastroenterology|October 10, 1997
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging studyF Nevens, J Main, P Honkoop, et al.Journal of Viral Hepatitis|March 27, 2001
Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patientS Seddigh-Tonekaboni, W L Lim, B Young, et al.Journal of Viral Hepatitis|October 31, 1998
Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapyP Honkoop, R A de Man, H G Niesters, et al.Caring : National Association for Home Care Magazine|June 22, 2005
Telehome care--legal advice for telehealth pioneersRobert J WatersAmerican Journal of Public Health|February 1, 1976
State level comprehensive health planning: a retrospectW J WatersEuropean Journal of Drug Metabolism and Pharmacokinetics|February 24, 2017
Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1LNigel J WatersCurrent Issues in Molecular Biology|August 8, 2001
Degradation of mutant proteins, underlying "loss of function" phenotypes, plays a major role in genetic diseaseP J WatersPageof 165